US Patent Issued to Angitia on May 19 for "Anti-sclerostin constructs and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,651, issued on May 19, was assigned to Angitia Inc. Ltd. (Woodland Hills, Calif.).

"Anti-sclerostin constructs and uses thereof" was invented by Xiaofeng Liu (Guangzhou, China), Kunfeng Liu (Guangzhou, China), Baozhi Yuan (Guangzhou, China), Muyu Li (Guangzhou, China) and Hua Zhu Ke (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides anti-Sclerostin constructs that bind to Sclerostin, nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin construct, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, p...